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Abstract 
Introduction: Squamous cell carcinoma represents about 90% of malignancies of the mouth and about 38% of the 
head and neck tumors. The behavior of the cancer is very aggressive, presenting early cervical metastasis and, often 
contralateral ranging from 0.9 to 36%. 
Objectives: This study aims to analyze clinical and pathological factors that may influence metastasis of squamous 
cell carcinoma in cervical lymph nodes and relate this occurrence in the contralateral primary tumor, with disease 
prognosis and the interference of this type of metastasis in the survival rate of patients with this pathology. 
Material and Metohds: It was conducted a retrospective study from medical records of patients with Squamous 
Cell Carcinomas with homolateral lymph node metastasis and contralateral attended at the clinic of Head and neck 
surgery of Hospital São Vicente de Paulo in Passo Fundo – RS - Brazil, from 2000 to 2008.
Results: Analyzing the charts of patients with metastatic and metastatic contralateral side it was observed that pa-
tients with initial stage presented a higher survival with statistical significance (p=0,035).
Conclusions: The occurrence of metastases in lymph nodes of contralateral position to the primary lesion was not 
the main fator that influenced the survival of the group.
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Introduction
Head and neck cancer is the fifth most common type of 
cancer worldwide, among all neoplasms. Approximately 
40% of them occur in the oral cavity. Squamous cell car-
cinoma was the most common histological type, with a 
frequency observed in the literature approximately 90%. 
The overall survival rate is variable, depending on the 
primary site, disease stage and also the occurrence of 
metastasis, resulting in an unfavorable prognosis (1).
The squamous cell carcinoma of the oral cavity presents 
a variable frequency of contralateral metastases between 
0.9% to 36%, reported in the literature. The presence of 
such metastases decreases the survival rate of the pa-
tients, on average, five years generating a poor prognosis 
(2).
Several clinical factors – pathological has been analy-
zed as predisposing to the development of contralateral 
lymph neck node metastasis [CLNM] of squamous cell 
carcinoma, such as: gender, location, extent, stage of 
primary tumor, positive ipsilateral lymph node involve-
ment of midline, degree of histological differentiation, 
surgical margins, growth pattern, thickness and perineu-
ral invasion. The most significant prognostic factors are 
the place and size of the primary tumor and the variables 
relating to lymph node metastasis, including the length, 
number, location and transcapsular involvement. These 
factors, if found in a meaningful way, reduce the pro-
bability of local and cervical control of the disease and 
survival rates (3).
The contralateral metastasis propagation can occur in 
the head and neck carcinoma by: passage in afferent 
lymphatic vessels and tumor spread along the midline, 
which reaches the side efferent lymphatic vessels, when 
ipsilateral lymph nodes are widely involved, and in cer-
tain anatomical areas where there is not a real barrier 
in the middle line (2). The squamous cell carcinoma of 
the oral cavity has a high incidence of micrometastases 
and often bilaterally metastases due the rich submucosal 
lymphatic plexus, that communicates freely crossing the 
midline (4).
This study aims to analyze clinical and pathological 
factors that may influence metastasis of squamous cell 
carcinoma in cervical lymph nodes and relate this occu-
rrence in the contralateral primary tumor, with disease 
prognosis and the interference of this type of metastasis 
in the survival rate of patients with this pathology.
Material and Methods
It was performed a retrospective study obtained by histo-
pathological findings in human tissue samples from 303 
patients with Squamous Cell Carcinoma. These samples 
were selected among patients who were treated in the 
ambulatory of head and neck surgery of the Hospital São 
Vicente de Paulo in Passo Fundo – RS - Brazil and sub-
mitted to a surgical procedure of lesion resection before 
they are submitted or not to Radiotherapy and/or Chemo-
therapy. Besides, it was analyzed the medical records of 
each patient doing a survey of clinical and pathological 
factors common among cases, that can classify patients 
at high risk for metastasis of squamous cell carcinoma 
in the contralateral lymph nodes of the neck. Data about 
ethnicities, age, education level, smoking habit, alcohol 
consumption, topographic location of the inicial lesion 
and tumor stage were collected.
For the clinical evaluation of patients with the disease, 
TNM system was used, standardized by UICC and Ame-
rican Joint Committee on Cancer [AJCC] (5). However, 
for N and M, it was considered the information available 
in medical records and archived paraffin blocks. Patients 
were classified according to the presence or absence of 
metastasis in ipsilateral  and contralateral lymph neck 
nodes.
For the histological tumor grading, it was used the OMS 
criteria, in which the tumors are classified as well, mode-
rately or poorly differentiated according to the degree of 
histological differentiation (6). For this evaluation was 
used the information already contained in the pathology 
report held by the pathologist in charge of the Pathology 
Service of the Hospital São Vicente de Paulo in Passo 
Fundo - Brasil.
It was excluded from the study cases with insufficient 
material, patients whose medical record data were in-
complete and all living patients or the date of death 
could not be analyzed were excluded from the study.
The collected data were analyzed by SPSS version 18 
using parametric test [Kolmogorov-Smirnov] and non-
parametric [Kruskal-Wallis; Mann-Whitney].
The project was approved by the Ethics Committee in 
Research of the Universidade de Passo Fundo and to 
the Hospital São Vicente de Paulo of Passo Fundo – RS, 
Brazil.
Results
From 303 patients initially studied, 106 demonstrated 
lymph node involvement, in other words, in the TNM 
classification the N ≥ 1, which were subdivided into pa-
tients with ipisilateral or contralateral lymph neck node 
metastasis.
For analysis of the influence of metastasis in contrala-
teral cervical lymph nodes on survival, it was discarded 
all patients who are alive and those who did not have the 
date of death for purposes of calculating the probability 
of the event [survival of the individual] throughout the 
period stipulated. The group with CLNM corresponded 
to 18.8% [n=15] and the group without CLNM 81.3% 
[n=65].
From the medical records of patients included in the 
analysis of the data of this research, the vast majority 
were men 93.8% [n=75] and only 6.3% [n=5] were wo-
men. The patients comprised only two ethnicities. White 
e211
J Clin Exp Dent. 2014;6(3):e209-13. Contralateral neck metastasis in squamous cell carcinoma.
in 92.5% [n=74] and Browns in 7.5% [n=6].
The decade of life most affected by the condition studied 
was the 5th decade in 36.3% of cases [n=29], followed 
by 26.3% 4th decade [n=21]. The education level was 
analyzed, and 85% [n=68] that reported this data, the 
majority had finished high school 70.6% [n=48] fo-
llowed by illiterate 11.8% [n=8], high school graduates 
7.4% [n=5], primary school graduates 5.9% [n=4] and 
college graduates 4.4% [n=3].
The topographic location of the initial lesion was 
grouped and considered the following locations: mouth 
floor 18.8% [n=15], tongue 50% [n=40], vestibule 15% 
[n=12], palate 11.3% [n=9] and other locations 5% 
[n=4].
The tumor stage at diagnosis could not only be observed 
in the records of a single patient. The stage I was obser-
ved in 8.8% of patients [n=7], stage II in 66.3% [n=53], 
stage III in 22.5% [n=18] and stage IV 1.3% [n=1].
The treatment used in each case was described in all 
medical records and distributed in surgical procedure 
[50%, n=40], radiotherapy [8.8%, n=7], chemotherapy 
[5%, n=4], combination of these types of treatments 
[25%, n=20], no treatment [7.5%, n=6], and other ty-
pes of treatments performed [3.8%, n=3]. Among the 
treatments used in patients with CLNM, the surgical co-
rresponded to 80% [n=12] and other forms of treatment 
20% [n=3]. From the patients with lateral lymph node 
involvement 44.6% [n=29] had surgical treatment and 
55.4% [n = 36] other types of treatments.
Smoking was informed by 85% [n = 68] of the medical 
records and was present in the habits of 91.2% [n = 62] 
of patients. Alcohol consumption was informed by 80% 
[n = 64] of patients, 90.6% [n=58] drinking (Table 1). 
These data were not crossed with survival due to the lar-
ge number of missing data.
It was performed the test of the survival curve and using 
the histogram analysis of patients with CLNM. The 
average survival was 17 months (Fig. 1). There was no 
statistically significant difference in survival of patients 
with ipsilateral lymph neck node metastasis and those 
with contralateral lymph neck node metastasis of site tu-
mor origin [p=0,086].
Survival probability begins to decrease regardless to 
have or not CLNM, from 65-70 months, and there is a 
50% chance of dying up to 50 months, more than 60% of 
patients have a chance of dying before 2 years (Fig. 2).
Later at intersections, the variables that lacked informa-
tion or classification were discarded and some data were 
adjusted for statistical purposes.
The staging was classified in initial, including patients 
with stages I and II, and late, patients with stages III and 
IV. In analyzing the graphics of the patients with and wi-
thout CLNM it was possible to notice that patients with 
initial staging showed a higher survival with statistical 
significance [p=0,035] (Figs. 3,4).
Of the patients with contralateral lymph neck node invol-
vement, 73.4% [n=11] were classified in initial staging 
at diagnosis, with a median survival of 32.6 months. Pa-
tients with late staging 26.6% [n = 4] had an average of 
13.0 months.
In comparison of each site in relation to metastasis, 
it was noted that among patients who had compromi-
sed contralateral lymph nodes and had initial tumor in 
floor demonstrated greater survival (Fig. 5).
Metastasis Gender Ethnicity Smoking Alcoholism
With CLNM
n= 15 (18.8%)
Male
 n=75 (93.8%)
White
n= 74 (92.5%)
Yes
n= 62 (91.2%)
Yes
n= 58 (90.6%)
Without CLNM
n= 65 (81.3%)
Female
n= 5 (6.3%)
Browns
n= 6 (7.5%)
No
n= 6 (8,8%)
No
n= 6 (9.4%)
Table 1. Prevalence of clinical aspects.
Fig.1. Histogram of the frequency of overall survival (months) 
of patients with contralateral metastasis who died from cancer.
Fig. 2. Graphic of the frequency of patients with CLNM and 
without CLNM with survival in months.
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There was a predominance of males [93.8%, n = 75] and 
only 6.3% [n = 5] were women agreeing with results of 
other studies (7,8). The highest incidence of squamous 
cell carcinoma occurs in the age group above 45 years 
old, with a higher prevalence in males and white people 
(1,9,10). Researchers believe with age increases the risk 
of developing cancer of the oral cavity by aggregating 
harmful effects of carcinogens (10). In the study the 
most affected decade of life by carcinoma was the 5th 
decade in 36.3% of cases [n=29]. Analyzing race, white 
patients were also more affected [92.5%, n=74].
Oral squamous cell carcinoma can occur anywhere in the 
mouth, being the most affected sites the tongue, lower 
lip and buccal floor. These regions are greatly facilita-
tors of the carcinoma spreading to regional lymph nodes 
and / or distant organs (11). The most affected segment 
by injury in both groups was the tongue [50%, n=40] 
followed by the floor of mouth [18.8%, n = 15], similar 
to that found in the literature. The topographical location 
of the lesion showed no statistical influence on survival, 
as well as of other studies (12,13).
In the group with CLNM 60% [n=9] presented initial 
injury in tongue and 13.4% [n=2] in floor of mouth. 
The clinical stage, tumor comprising the midline and 
involvement of floor of mouth, were the main factors 
predisposing to CLNM. Patients with primary tumors in 
floor of the mouth had a 50% higher risk of contralate-
ral metastasis than those with tumors in tongue (14). In 
the study, patients with initial tumor in the tongue repre-
sented 60% of the group with contralateral lymph node 
involvement.
The advanced clinical TNM and tumor size can be con-
sidered important factors that favor the development of 
CLNM, being as important as the location of the tumor 
and involvement midline (7). The stage which the tu-
mor is at diagnosis shows itself a very important factor 
when observed patient survival. Metastatic lymph nodes 
represent one of the most relevant aspects associated 
with treatment, characterizing an advanced clinical stage 
[stages III or IV], and it is associated with a 50% reduc-
tion in survival (15). This study shows that patients with 
CLNM and late staging live an average of 13.0 months, 
while in the initial staging 32.6 months. When analyzed 
patients who were diagnosed in the early stages of the 
disease, there was a survival in months higher than those 
diagnosed at later stages.
Analyzing both groups together [n=80], it was observed 
that patients with initial stage showed a significantly 
higher survival [p=0,035]. When analyzing the separate 
groups, could still be observed difference in survival of 
patients with initial staging from those with late staging. 
Therefore, metastasis was not the main influencing fac-
tor on the survival of the group with contralateral lymph 
node involvement.
Neck treatment with metastatic is the radical dissection, 
Fig. 3. Graphic of the interval of survival in months of the 
patients who died, according to staging.
Fig. 4. Graphic of survival in months of patients with con-
tralateral lymph node involvement who died, according to the 
staging.
Fig. 5. Graphic of survival in patients with contralateral lymph 
node involvement who died according to the topographical lo-
cation of injury diagnosis.
Discussion
In the study, patients with CLNM corresponded to the 
smallest group with 18.8% (n = 15) and patients without 
CLNM corresponded to 81.3% (n = 65), similar to the pre-
vious study, where the CLNM group was also lower (7). 
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contemplating possible changes related to the preser-
vation of non-lymphatic structures. In view of the high 
rates of occult metastases ipsilateral and contralateral 
neck in an untreated neck and the poor salvage rates for 
failures at the neck, elective neck treatment of the N0 
neck had been proposed by  investigators as reported 
in the literature (16). Among the treatments performed, 
the radical surgical procedure was the most recommen-
ded, followed by combining this with radiotherapy or 
chemotherapy either in the analysis of both groups. The 
combination of concurrent chemo-therapy and radiothe-
rapy has become standard treatment for many patients 
with improved locoregional control and overall survival 
when compared with radiotherapy alone (17), justifying 
the small percentage of this treatment option, being 
more used when the patient has no clinical conditions to 
undergo surgery.
Analyzed studies have reported that the recurrence of 
the primary lesion and the presence of metastasis in cer-
vical lymph neck nodes contralateral affect the survival 
rate of patients with squamous cell carcinoma of the oral 
cavity [CCE], thereby generating, an unfavorable prog-
nosis (2).
When comparing the survival of patients with CLNM 
with patients without CLNM, there was no statistical 
difference between the groups, agreeing with results of 
another study (18). However, the probability starts de-
creasing regardless of whether or not to have metasta-
sized, from 65-70 months, and there is a 50% chance 
of dying up to 50 months, more than 60% of patients 
are likely to die before 2 years, similar to the findings 
of the literature reporting high probability of dying be-
fore age 5 (3,7). It should be remembered that all pa-
tients who are part of the study, already had lymph neck 
node metastasis, however, some ipisilateral and others 
contralateral, this already means an advanced stage of 
the disease. Study reported not finding a poor prognosis 
in patients with metastasis in a single lymph node and 
contralateral metastases limited to levels 1 and 2 (3). In 
the study there were no data about the amount and level 
of contralateral metastatic lymph nodes, hypothesis that 
could have generated no statistical significance in survi-
val between the groups. 
The occurrence of lymph node metastasis of contralate-
ral position to the primary lesion was not the main factor 
that influenced the survival of the group. It is necessary 
emphasizes the importance of early diagnosis, preven-
ting squamous cell carcinoma to reach an advanced sta-
ge.
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